UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

Leukemia, 2008-02, Vol.22 (2), p.258-264

2008

Volltextzugriff (PDF)

Microbial contamination of hematopoietic progenitor cell products: clinical outcome

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (4), p.365-368

2007

Volltextzugriff (PDF)

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML MDS patients receiving allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (5), p.461-464

2007

Volltextzugriff (PDF)

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

Haematologica (Roma), 2009-02, Vol.94 (2), p.249-257

2009

Volltextzugriff (PDF)

Microbial contamination of hematopoietic progenitor cell products: clinical outcome

Bone marrow transplantation (Basingstoke), 2007-08, Vol.40 (3), p.365

2007

Volltextzugriff (PDF)

There will be conflict – agricultural landscapes are prime, rather than marginal, habitats for Asian elephants

Animal conservation, 2021-10, Vol.24 (5), p.720-732

2021

Volltextzugriff (PDF)

Recent Improvement Strategies on Metal-Organic Frameworks as Adsorbent, Catalyst, and Membrane for Wastewater Treatment

Molecules (Basel, Switzerland), 2021-08, Vol.26 (17), p.5261

2021

Volltextzugriff (PDF)

Towards tolerable human–elephant coexistence in tropical Asia

Animal conservation, 2021-10, Vol.24 (5), p.740-742

2021

Volltextzugriff (PDF)

OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

Hematological oncology, 2023-06, Vol.41 (S2), p.134-136

2023

Volltextzugriff (PDF)

Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.9475-9477

2022

Volltextzugriff (PDF)

A New Subspecies Identification and Population Study of the Asian Small-Clawed Otter (Aonyx cinereus) in Malay Peninsula and Southern Thailand Based on Fecal DNA Method

TheScientificWorld, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

Efficacy and Safety of Golcadomide, a Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, Combined with Rituximab in a Phase 1/2 Open-Label Study of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.4496-4496

2023

Volltextzugriff (PDF)

THREE PHASE 1/2, OPEN‐LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)‐BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

128PMultiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

128P - Multiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

Annals of oncology, 2019-10, Vol.30, p.v40-v40

2019

Volltextzugriff (PDF)

Multiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

Annals of oncology, 2019-10, Vol.30, p.v40

2019

Volltextzugriff (PDF)

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

Haematologica (Roma), 2010-07, Vol.95 (7), p.1183-1190

2010

Volltextzugriff (PDF)

Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors

ESMO open, 2023-04, Vol.8 (2), p.100784-100784, Article 100784

2023

Volltextzugriff (PDF)

A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Living With Elephants: Evidence-Based Planning to Conserve Wild Elephants in a Megadiverse South East Asian Country

Frontiers in conservation science, 2021-07, Vol.2

2021

Volltextzugriff (PDF)

Habitat and food resources of otters (Mustelidae) in Peninsular Malaysia

AIP Conference Proceedings, 2014, Vol.1614 (1), p.699

2014

Volltextzugriff (PDF)

S216: CLINICAL ACTIVITY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN‐LABEL STUDY

HemaSphere, 2022-06, Vol.6, p.117-118

2022

Volltextzugriff (PDF)

Aiding pest control management of long-tailed macaques (Macaca fascicularis fascicularis) in Malaysia by using molecular markers of mitochondrial DNA

AIP Conference Proceedings, 2017, Vol.1891 (1)

2017

Volltextzugriff (PDF)

Pandemic influenza A H1N1 09 virus infection in hematopoietic SCT recipient

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.467-468

2011

Volltextzugriff (PDF)

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML

Bone marrow transplantation (Basingstoke), 2009-05, Vol.43 (9), p.685-692

2009

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(12)
Humans
(8)
Hematology
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Oncology
(6)
Stem Cell Transplantation
(6)
Transplantation, Homologous
(6)
Adult
(5)
Aged
(5)
Male
(5)
Middle Aged
(5)
Transplantation
(5)
Biophysics
(4)
Female
(4)
Hematologic And Hematopoietic Diseases
(4)
Hematopoietic Stem Cells
(4)
Immunology
(4)
Stem Cells
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

Microbial contamination of hematopoietic progenitor cell products: clinical outcome

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML MDS patients receiving allogeneic hematopoietic stem cell transplantation

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

Microbial contamination of hematopoietic progenitor cell products: clinical outcome

There will be conflict – agricultural landscapes are prime, rather than marginal, habitats for Asian elephants

Recent Improvement Strategies on Metal-Organic Frameworks as Adsorbent, Catalyst, and Membrane for Wastewater Treatment

Towards tolerable human–elephant coexistence in tropical Asia

OPEN‐LABEL PHASE 1/2 STUDY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma

A New Subspecies Identification and Population Study of the Asian Small-Clawed Otter (Aonyx cinereus) in Malay Peninsula and Southern Thailand Based on Fecal DNA Method

Efficacy and Safety of Golcadomide, a Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, Combined with Rituximab in a Phase 1/2 Open-Label Study of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

THREE PHASE 1/2, OPEN‐LABEL STUDIES OF CEREBLON E3 LIGASE MODULATOR (CELMOD)‐BASED REGIMENS IN NEWLY DIAGNOSED (ND) OR RELAPSED/REFRACTORY (R/R) NON‐HODGKIN LYMPHOMA (NHL)

128PMultiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

128P - Multiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

Multiplex chromogenic Immunohistochemistry (IHC) for spatial analysis of checkpoint-positive tumour infiltrating lymphocytes (TILs)

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors

A PHASE 1, MULTICENTER, OPEN‐LABEL STUDY OF CC‐99282 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS

Living With Elephants: Evidence-Based Planning to Conserve Wild Elephants in a Megadiverse South East Asian Country

Habitat and food resources of otters (Mustelidae) in Peninsular Malaysia

S216: CLINICAL ACTIVITY OF CC‐99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON‐HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN‐LABEL STUDY

Aiding pest control management of long-tailed macaques (Macaca fascicularis fascicularis) in Malaysia by using molecular markers of mitochondrial DNA

Pandemic influenza A H1N1 09 virus infection in hematopoietic SCT recipient

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML

Suchergebnisse filtern